FDA Drug Establishment Registration Services
Cert3Global provides professional FDA Drug Establishment Registration Services for domestic and foreign drug establishments seeking to market their products in the United States. We assist pharmaceutical companies with FDA establishment registration and drug listing requirements, helping ensure compliance with U.S. regulatory obligations and supporting a smooth path to market entry.
Our team works with finished drug manufacturers, API manufacturers, brand owners, repackers, relabelers, and drug testing laboratories to simplify the registration process and help maintain regulatory readiness.
Expert FDA Drug Establishment Registration Support for Global Manufacturers
The U.S. Food and Drug Administration (FDA) requires domestic and foreign establishments that manufacture, prepare, propagate, compound, repack, relabel, or process drug products for commercial distribution in the United States to register with the agency and list their commercially marketed drug products.
FDA Drug Establishment Registration is a critical step for companies planning to manufacture, import, or distribute drug products in the U.S. market. Proper registration and drug listing help FDA maintain an inventory of establishments and marketed drug products while supporting inspections, supply chain monitoring, and regulatory oversight.
Cert3Global provides structured support throughout the registration process, helping manufacturers understand requirements, prepare necessary information, and complete FDA establishment registration and drug listing activities efficiently and accurately.
What is FDA Drug Establishment Registration?
FDA Drug Establishment Registration is the process through which pharmaceutical establishments notify the FDA about the facilities where drugs are manufactured, repacked, relabeled, tested, or processed for commercial distribution in the United States. The registration process is accompanied by drug listing requirements, which provide the FDA with information about commercially marketed drug products.
Registration information is submitted electronically through the FDA’s Electronic Drug Registration and Listing System (eDRLS) using Structured Product Labeling (SPL) files. The information submitted helps FDA maintain oversight of the pharmaceutical supply chain and supports inspections, recalls, post-market surveillance, and other regulatory activities.
It is important to understand that establishment registration does not mean FDA approval of a drug product. Instead, it confirms that the required establishment and product information has been submitted to the agency as required by applicable regulations.
Who Needs FDA Drug Establishment Registration?
- Finished drug manufacturers
- Active Pharmaceutical Ingredient (API) manufacturers
- Brand owners
- Drug repackers and relabelers
- Contract manufacturing organizations
- Drug testing laboratories
- Importers of drug products
- Sterilization and processing facilities
Why is FDA Drug Establishment Registration Important?
Key Benefits:
- Supports lawful marketing of drug products in the United States
- Facilitates import and distribution activities
- Helps maintain regulatory compliance
- Demonstrates operational readiness to business partners and customers
- Enables efficient communication with the FDA
- Supports supply chain transparency and product traceability
Completing registration correctly and maintaining accurate records can significantly reduce regulatory risks and support long-term business growth in the U.S. market.
FDA Drug Establishment Registration Services You Can Rely On
Registration Requirement Assessment
We assess your business activities and determine the applicable FDA establishment registration and drug listing requirements.
FDA Establishment Registration Support
We assist with preparation and submission of establishment registration information for domestic and foreign pharmaceutical facilities.
Drug Listing Support
Our team helps prepare and submit drug listing information and product details required for commercially marketed drug products.
SPL Documentation Assistance
We support the preparation and management of Structured Product Labeling (SPL) files required for electronic registration and listing submissions.
Registration Updates and Maintenance
We assist with maintaining accurate registration records and managing updates when facility or product information changes.
Annual Registration Renewal Support
FDA requires annual renewal of establishment registration between October 1 and December 31. We support manufacturers in maintaining ongoing compliance with these obligations.
FDA Drug Establishment Registration Process
Step 1: Determine Registration Requirements
Step 2: Gather Establishment Information
Step 3: Prepare Electronic Submission
Step 4: Submit Registration and Drug Listings
Step 5: Maintain Registration
Why Choose Cert3Global?
- End-to-end FDA registration support
- Experience working with domestic and foreign establishments
- Drug listing and SPL submission assistance
- Ongoing registration maintenance support
- Regulatory guidance focused on compliance and efficiency
- Dedicated support throughout the registration process
Start Your FDA Drug Establishment Registration Process!
Entering the U.S. pharmaceutical market requires proper establishment registration and drug listing compliance. Cert3Global helps pharmaceutical companies navigate FDA requirements with confidence through structured guidance and practical support.
Whether you are a finished drug manufacturer, API manufacturer, brand owner, or testing laboratory, our team is ready to support your FDA registration journey.